Gout and Progression of Aortic Stenosis

Published:February 18, 2020DOI:



      Patients with aortic stenosis are nearly twice as likely to have a diagnosis of gout compared with individuals without aortic valve disease.


      This retrospective study evaluated consecutive adults age ≥65 years with aortic stenosis between December 2012 and November 2016 who underwent at least 2 transthoracic echocardiograms (TTEs) separated by at least 1 year. Severe aortic stenosis was defined as any combination of an aortic valve peak velocity ≥4.0 m/sec, mean gradient ≥40 mm Hg, aortic valve area ≤1 cm2, or decrease in left ventricular ejection fraction as a result of aortic stenosis.


      Of the 699 study patients, gout was present in 73 patients (10%) and not found in 626 patients (90%). Median follow-up was 903 days [552-1302] for patients with gout and 915 days [601-1303] for patients without gout (P = 0.60). The presence of severe aortic stenosis on follow-up transthoracic echocardiogram was more frequent in patients with gout compared to those without gout (74% vs 54%, P = 0.001; hazard ratio [HR] 1.45 [1.09-1.93]), even among the 502 patients without severe aortic stenosis at baseline (63% vs 39%, P = 0.003; hazard ratio 1.43 [1.07-1.91]). Gout remained associated with the development of severe aortic stenosis after multivariable adjustment (adjusted hazard ratio [aHR] 1.46 [1.03-2.08], P = 0.03). The annualized reduction in aortic valve area was numerically greater in the group with gout compared with the group without gout (−0.10 cm2/y [−0.18, −0.03] vs −0.08 cm2/y [−0.16, −0.01], P = 0.09); annualized change in peak velocity and mean gradient did not differ between groups.


      Progression to severe aortic stenosis was more frequent in patients with gout compared with those without gout, supporting the hypothesis that gout is a risk factor for aortic stenosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nkomo VT
        • Gardin JM
        • Skelton TN
        • Gottdiener JS
        • Scott CG
        • Enriquez-Sarano M
        Burden of valvular heart diseases: a population-based study.
        Lancet. 2006; 368: 1005-1011
      1. Society of Thoracic Surgeons. STS Adult Cardiac Surgery Database Executive Summary - 2017 Harvest 2. Available at: Accessed May 10, 2019.

        • Kuo C-F
        • Yu K-H
        • See L-C
        • et al.
        Risk of myocardial infarction among patients with gout: a nationwide population-based study.
        Rheumatology. 2013; 52: 111-117
        • Krishnan E
        Gout and the risk for incident heart failure and systolic dysfunction.
        BMJ Open. 2012; 2e000282
        • Choi HK
        • Curhan G
        Independent impact of gout on mortality and risk for coronary heart disease.
        Circulation. 2007; 116: 894-900
        • Clarson LE
        • Hider SL
        • Belcher J
        • Heneghan C
        • Roddy E
        • Mallen CD
        Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink.
        Ann Rheum Dis. 2015; 74: 642-647
        • Shah A
        • Keenan RT
        Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?.
        Curr Rheumatol Rep. 2010; 12: 118-124
        • Chang K
        • Yokose C
        • Tenner C
        • et al.
        Association between gout and aortic stenosis.
        Amer J Med. 2017; 130: 230.e1-230.e8
        • Feig DI
        • Kang DH
        • Johnson RJ
        Uric acid and cardiovascular risk.
        N Engl J Med. 2008; 359: 1811-1821
        • Berezin AE
        • Kremzer AA
        Serum uric acid as a marker of coronary calcification in patients with asymptomatic coronary artery disease with preserved left ventricular pump function.
        Cardiol Res Pract. 2013; 2013129369
        • Atar AI
        • Yilmaz OC
        • Akin K
        • et al.
        Serum uric acid level is an independent risk factor for presence of calcium in coronary arteries: an observational case-controlled study.
        Anadolu Kardiyol Derg. 2013; 13: 139-145
        • Liu Z
        • Chen T
        • Niu H
        • et al.
        The establishment and characteristics of rat model of atherosclerosis induced by hyperuricemia.
        Stem Cells Int. 2016; 20161365257
        • Demir B
        • Caglar IM
        • Ugurlucan M
        • et al.
        The relationship between severity of calcific aortic stenosis and serum uric acid levels.
        Angiology. 2012; 63: 603-608
        • Klauser AS
        • Halpern EJ
        • Strobl S
        • et al.
        Dual-energy computed tomography detection of cardiovascular monosodium urate deposits in patients with gout [e-pub ahead of print].
        JAMA Cardiol. 2019 Sep 11; (Accessed March 3, 2020)